Horizon Branches Out With Oncology Program
This article was originally published in Scrip
Stepping away from its usual research service agreements, Horizon Discovery Group Plc. has signed an in-licensing and option agreement with French pharma company Servier Laboratories for an oncology program.
Register for our free email digests: